Psychotherapy and Psychosomatics

‘Psychotherapy and Psychosomatics’ has progressively increased its reputation for independence, originality and methodological rigor. It has anticipated and developed new lines of research concerned with psychosomatic medicine, psychotherapy research and psychopharmacology. The journal features editorials and reviews on current and controversial issue; innovations in assessment and treatment; case management articles; original investigations; literature updates; and a lively correspondence section.

Publisher
Karger
Website
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=223864
Impact factor
6.284 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Psychology & Psychiatry

Computer training to reduce trauma symptoms

Computer training applied in addition to psychotherapy can potentially help reduce the symptoms of post-traumatic stress disorder (PTSD). These are the results found by researchers from Ruhr-Universität Bochum and their ...

Psychology & Psychiatry

Should doctors talk about the placebo effect with their patients?

Clinical and laboratory studies demonstrate that placebo and nocebo effects influence various symptoms and conditions after the administration of both inert and active treatments. There is an increasing need for up-to-date ...

Psychology & Psychiatry

The effect of psychotherapy on functional medical disorders

Functional somatic disorders are common and costly, thereby driving the need for the development of effective brief treatment options. Short-term psychodynamic psychotherapy is one candidate treatment method. This study aimed ...

Psychology & Psychiatry

How psychotherapy can be provided in times of COVID-19

The impact of the COVID-19 pandemic underscores the potential public health significance of broader dissemination of modes of therapy for both depressive and anxiety disorders that do not require the patient and therapist ...

Psychology & Psychiatry

When psychotropic medications are used as recreational drugs

Recreational, abused drugs (e.g., cannabinoids; cocaine; and MDMA/ecstasy) appear to increase dopaminergic signaling in the mesolimbic reward pathway which, in turn, reinforces the subjective rewarding, and euphoric effects ...

page 1 from 14